Management of Patients with Hepatic Encephalopathy

For the management of recurrent or persistent hepatic encephalopathy (HE), use a medical treatment like nonabsorbable disaccharides + rifaximin and avoid precipitating factors.
In patients refractory to treatment, consider spontaneous portosystemic shunts (SPSS) (abdominal CT/MRI).
In the presence of SPSS and MELD score ≤11, no significant PHrelated complications and technical feasibility of embolization = consider embolization.
In the presence of SPSS and model for end-stage liver disease (MELD) scores 12-14, consider each case individually. In the presence of SPSS and MELD score ≥15, significant PH-related complications, and technical difficulties for embolization = consider liver transplant.

Dr. Sunil Taneja

Dr. Sunil Taneja is an Postgraduate Institute of Medical Education and Research PGIMER Department of Hepatology. He has completed MD, DM.

Please login to comment on this article

Related FAQs

HCC Staging: What is New in INASL Guidelines (2023..

Reducing Deaths from ACLF is a Realistic Goal..

HBV RNA and HBcrAg: Biomarkers of Disease Activity..

Rifaximin Alone vs. Combination with Norfloxacin f..

Drugs to Treat Chronic Hepatitis B in Children..

Management of Lean Patients with NAFLD (MASLD)..

Refractory Ascites - Newer Concepts in the Managem..

LTx for Acute-on-Chronic Liver Failure: Don’t Ru..

Biomarker Strategies for Significant and Advanced ..

Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks

Quick Links

Useful Links

Medbytes FAQ

About Us

Medtalks TV

Webinars

CMEs

Terms And Conditions

Conferences